Ross Osborn

Ross Osborn, CFA, currently serves as the Director and Lead Research Analyst for MedTech & Diagnostics at Cantor Fitzgerald since November 2021, following a role as Vice President and Lead Research Analyst in the same sector. Prior to that, Ross worked at Stephens from June 2018 to September 2021 as an Equity Research Senior Associate focused on MedTech. Additionally, Ross gained experience as an Equity Research Summer Analyst at BMO Capital Markets in 2017 and at Anchor Capital Management Company in 2016. Ross Osborn holds a degree from Wake Forest University, completed in May 2018.